Li Pengmei
Senior Pharmacist | Professional Master's Supervisor
Research Interests: Therapeutic Drug Monitoring & Individualized Medication
Tel: +86-010-84205370
Email:lipengmei@yeah.net
EDUCATION
Master of Science,China Pharmaceutical University（2005）
Bachelor of Science, China Pharmaceutical University (2002)
PROFESSIONAL EXPERIENCE
2005 - present China-Japan Friendship Hospital , Department of Pharmacy
Deputy Director (2018)，Pharmacist (2005），Pharmacist in Charge(2010)，Associate Senior Pharmacist（2015），Senior Pharmacist（2022）
2021 - present Peking University, School of Pharmaceutical Sciences, Department of Pharmacy Administration and Clinical Pharmacy
Professional Master Supervisor (2021)
ACADEMIC APPOINTMENTS
Chinese Pharmaceutical Association，Hospital Pharmacy Professional Committee，Pharmaceutical Informatics Professional Committee，Member,（2023）
Chinese Pharmacological Society，Therapeutic drug monitoring Research Professional Committee, Member（2024）
China Association of Chinese Materia Medica，CMM Toxicology & Safety Research Branch, Member(2023)
AWARDS AND CERTIFICATES
Outstanding Teaching Administrator,China-Japan Friendship Hospital（2020）
Advanced Individual, Striving for Excellence Campaign, China-Japan Friendship Hospital（2012）
Outstanding Resident Physician, China-Japan Friendship Hospital（2010）
REPRESENTATIVE PUBLICATIONS(2023-2025)
1. Zhang D, Wang X, Du W, Qin W, Chen W, Zuo X, Li P. Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients. Pulm Pharmacol Ther. 2023 Oct;82:102243.
2. Xiong Y, Liu X, Wang Q, Zhao L, Kong X, Da C, Meng Z, Qu L, Xia Q, Liu L, Li P. Machine learning-based prediction model for the efficacy and safety of statins. Front Pharmacol. 2024 Jul 29;15:1334929.
3.Du W, Wang X, Zhang D, Chen W, Zuo X, Li P. A genotype-guided prediction model for the incidence of persistent acute kidney injury following lung transplantation. BMC Nephrol. 2024 Dec 18;25(1):458.
4.Liu X, Li B, Li S, Wang X, Kong X, Chen Y, Zhang Q, Duan J, Chen W, Li P. Simultaneous determination of three β-Lactam/β-lactamase inhibitor combinations in critically ill patients by UPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2025 Jan 15;1251:124431.
5.Liu X, Chen W, Du W, Li P, Wang X. Application of artificial intelligence and machine learning in lung transplantation: a comprehensive review. Front Digit Health. 2025 May 1;7:1583490.
6.Chi H, Li S, Liu F, Li B, Chen W, Zhang C, Zhou W, Yang M, Li P. Development of a validated and sensitive ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method to simultaneous determination of crizotinib, alectinib and lorlatinib in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2025 Dec 15;1267:124770.